These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
728 related articles for article (PubMed ID: 31821099)
1. Comparison of Initial Experience with Transrectal Magnetic Resonance Imaging Cognitive Guided Micro-Ultrasound Biopsies versus Established Transperineal Robotic Ultrasound Magnetic Resonance Imaging Fusion Biopsies for Prostate Cancer. Claros OR; Tourinho-Barbosa RR; Fregeville A; Gallardo AC; Muttin F; Carneiro A; Stabile A; Moschini M; Macek P; Cathala N; Mombet A; Sanchez-Salas R; Cathelineau X J Urol; 2020 May; 203(5):918-925. PubMed ID: 31821099 [TBL] [Abstract][Full Text] [Related]
2. Prostate Mapping for Cancer Diagnosis: The Madrid Protocol. Transperineal Prostate Biopsies Using Multiparametric Magnetic Resonance Imaging Fusion and Micro-Ultrasound Guided Biopsies. Rodríguez Socarrás ME; Gomez Rivas J; Cuadros Rivera V; Reinoso Elbers J; Llanes González L; Michel Mercado I; Fernandez Del Alamo J; Juarez Del Dago P; Sancha FG J Urol; 2020 Oct; 204(4):726-733. PubMed ID: 32314932 [TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of transperineal template saturation prostate biopsy versus magnetic resonance imaging targeted biopsy with magnetic resonance imaging-ultrasound fusion guidance. Radtke JP; Kuru TH; Boxler S; Alt CD; Popeneciu IV; Huettenbrink C; Klein T; Steinemann S; Bergstraesser C; Roethke M; Roth W; Schlemmer HP; Hohenfellner M; Hadaschik BA J Urol; 2015 Jan; 193(1):87-94. PubMed ID: 25079939 [TBL] [Abstract][Full Text] [Related]
4. Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer. Kuru TH; Roethke MC; Seidenader J; Simpfendörfer T; Boxler S; Alammar K; Rieker P; Popeneciu VI; Roth W; Pahernik S; Schlemmer HP; Hohenfellner M; Hadaschik BA J Urol; 2013 Oct; 190(4):1380-6. PubMed ID: 23608676 [TBL] [Abstract][Full Text] [Related]
5. The detection of significant prostate cancer is correlated with the Prostate Imaging Reporting and Data System (PI-RADS) in MRI/transrectal ultrasound fusion biopsy. Cash H; Maxeiner A; Stephan C; Fischer T; Durmus T; Holzmann J; Asbach P; Haas M; Hinz S; Neymeyer J; Miller K; Günzel K; Kempkensteffen C World J Urol; 2016 Apr; 34(4):525-32. PubMed ID: 26293117 [TBL] [Abstract][Full Text] [Related]
6. Magnetic Resonance and Ultrasound Image Fusion Supported Transperineal Prostate Biopsy Using the Ginsburg Protocol: Technique, Learning Points, and Biopsy Results. Hansen N; Patruno G; Wadhwa K; Gaziev G; Miano R; Barrett T; Gnanapragasam V; Doble A; Warren A; Bratt O; Kastner C Eur Urol; 2016 Aug; 70(2):332-40. PubMed ID: 26995327 [TBL] [Abstract][Full Text] [Related]
7. The Institutional Learning Curve of Magnetic Resonance Imaging-Ultrasound Fusion Targeted Prostate Biopsy: Temporal Improvements in Cancer Detection in 4 Years. Meng X; Rosenkrantz AB; Huang R; Deng FM; Wysock JS; Bjurlin MA; Huang WC; Lepor H; Taneja SS J Urol; 2018 Nov; 200(5):1022-1029. PubMed ID: 29886090 [TBL] [Abstract][Full Text] [Related]
8. Optimizing the Number of Cores Targeted During Prostate Magnetic Resonance Imaging Fusion Target Biopsy. Kenigsberg AP; Renson A; Rosenkrantz AB; Huang R; Wysock JS; Taneja SS; Bjurlin MA Eur Urol Oncol; 2018 Oct; 1(5):418-425. PubMed ID: 31158081 [TBL] [Abstract][Full Text] [Related]
10. Accuracy of Transperineal Targeted Prostate Biopsies, Visual Estimation and Image Fusion in Men Needing Repeat Biopsy in the PICTURE Trial. Simmons LAM; Kanthabalan A; Arya M; Briggs T; Barratt D; Charman SC; Freeman A; Hawkes D; Hu Y; Jameson C; McCartan N; Moore CM; Punwani S; van der Muelen J; Emberton M; Ahmed HU J Urol; 2018 Dec; 200(6):1227-1234. PubMed ID: 30017964 [TBL] [Abstract][Full Text] [Related]
11. Accuracy of real-time magnetic resonance imaging-transrectal ultrasound fusion image-guided transperineal target biopsy with needle tracking with a mechanical position-encoded stepper in detecting significant prostate cancer in biopsy-naïve men. Shoji S; Hiraiwa S; Ogawa T; Kawakami M; Nakano M; Hashida K; Sato Y; Hasebe T; Uchida T; Tajiri T Int J Urol; 2017 Apr; 24(4):288-294. PubMed ID: 28222486 [TBL] [Abstract][Full Text] [Related]
12. Not All Multiparametric Magnetic Resonance Imaging-targeted Biopsies Are Equal: The Impact of the Type of Approach and Operator Expertise on the Detection of Clinically Significant Prostate Cancer. Stabile A; Dell'Oglio P; Gandaglia G; Fossati N; Brembilla G; Cristel G; Dehò F; Scattoni V; Maga T; Losa A; Gaboardi F; Cardone G; Esposito A; De Cobelli F; Del Maschio A; Montorsi F; Briganti A Eur Urol Oncol; 2018 Jun; 1(2):120-128. PubMed ID: 31100235 [TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance imaging/transrectal ultrasound fusion-targeted prostate biopsy using three-dimensional ultrasound-based organ-tracking technology: Initial experience in Japan. Yamada Y; Fujihara A; Shiraishi T; Ueda T; Yamada T; Ueno A; Inoue Y; Kaneko M; Kamoi K; Hongo F; Okihara K; Ukimura O Int J Urol; 2019 May; 26(5):544-549. PubMed ID: 30793385 [TBL] [Abstract][Full Text] [Related]
14. Impact of Lesion Visibility on Transrectal Ultrasound on the Prediction of Clinically Significant Prostate Cancer (Gleason Score 3 + 4 or Greater) with Transrectal Ultrasound-Magnetic Resonance Imaging Fusion Biopsy. Garcia-Reyes K; Nguyen HG; Zagoria RJ; Shinohara K; Carroll PR; Behr SC; Westphalen AC J Urol; 2018 Mar; 199(3):699-705. PubMed ID: 28941918 [TBL] [Abstract][Full Text] [Related]
15. Multicentre evaluation of targeted and systematic biopsies using magnetic resonance and ultrasound image-fusion guided transperineal prostate biopsy in patients with a previous negative biopsy. Hansen NL; Kesch C; Barrett T; Koo B; Radtke JP; Bonekamp D; Schlemmer HP; Warren AY; Wieczorek K; Hohenfellner M; Kastner C; Hadaschik B BJU Int; 2017 Nov; 120(5):631-638. PubMed ID: 27862869 [TBL] [Abstract][Full Text] [Related]
16. Multiparametric Magnetic Resonance Imaging-Ultrasound Fusion Biopsy Improves but Does Not Replace Standard Template Biopsy for the Detection of Prostate Cancer. Hanna N; Wszolek MF; Mojtahed A; Nicaise E; Wu B; Gelpi-Hammerschmidt FJ; Salari K; Dahl DM; Blute ML; Harisinghani M; Feldman AS J Urol; 2019 Nov; 202(5):944-951. PubMed ID: 31144593 [TBL] [Abstract][Full Text] [Related]
17. Anterior Localization of Prostate Cancer Suspicious Lesions in 1,161 Patients Undergoing Magnetic Resonance Imaging/Ultrasound Fusion Guided Targeted Biopsies. Leyh-Bannurah SR; Kachanov M; Beyersdorff D; Preisser F; Tilki D; Fisch M; Graefen M; Budäus L J Urol; 2018 Nov; 200(5):1035-1040. PubMed ID: 29935274 [TBL] [Abstract][Full Text] [Related]
18. Detection of significant prostate cancer with magnetic resonance targeted biopsies--should transrectal ultrasound-magnetic resonance imaging fusion guided biopsies alone be a standard of care? Delongchamps NB; Lefèvre A; Bouazza N; Beuvon F; Legman P; Cornud F J Urol; 2015 Apr; 193(4):1198-204. PubMed ID: 25451824 [TBL] [Abstract][Full Text] [Related]
19. How Many Targeted Biopsy Cores are Needed for Clinically Significant Prostate Cancer Detection during Transperineal Magnetic Resonance Imaging Ultrasound Fusion Biopsy? Song G; Ruan M; Wang H; Fan Y; He Q; Lin Z; Li X; Li P; Wang X; He Z; Zhou L J Urol; 2020 Dec; 204(6):1202-1208. PubMed ID: 32716686 [TBL] [Abstract][Full Text] [Related]
20. Transperineal prostate biopsy with cognitive magnetic resonance imaging/biplanar ultrasound fusion: description of technique and early results. Gorin MA; Meyer AR; Zimmerman M; Harb R; Joice GA; Schwen ZR; Allaf ME World J Urol; 2020 Aug; 38(8):1943-1949. PubMed ID: 31679065 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]